Global Checkpoint Inhibitors for Treating Cancer Market
85 Pages | Healthcare

Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2018-2028

  • Published Date : 14-12-2021
  • Pages : 85
  • Report Id : 60789
  • Categories : Healthcare

Summary
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2022 with CAGR xx% 2022-2028. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol-Myers Squibb(BMS)
Merck
Roche
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Melanoma treatment
Bladder cancer treatment
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Checkpoint Inhibitors for Treating Cancer Picture
1.1.2 Specifications
Table Product Specifications of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2018-2028 (USD Million)
1.2.1.1 PD-1 inhibitors
Table PD-1 inhibitors Overview
1.2.1.2 PD-L1 inhibitors
Table PD-L1 inhibitors Overview
1.2.1.3 CTLA-4 inhibitors
Table CTLA-4 inhibitors Overview
1.2.2 by Application
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2018-2028 (USD Million)
1.2.2.1 Melanoma treatment
Table Melanoma treatment Overview
1.2.2.2 Bladder cancer treatment
Table Bladder cancer treatment Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2018-2028 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Checkpoint Inhibitors for Treating Cancer
2.2 Upstream
Table Cost of Checkpoint Inhibitors for Treating Cancer
Figure Manufacturing Process of Checkpoint Inhibitors for Treating Cancer
2.3 Market
2.3.1 SWOT
Figure SWOT of Checkpoint Inhibitors for Treating Cancer
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Checkpoint Inhibitors for Treating Cancer
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Checkpoint Inhibitors for Treating Cancer
3.4 Market Entry
Table Market Entry of Checkpoint Inhibitors for Treating Cancer
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PD-1 inhibitors Market, 2017-2021
Figure PD-1 inhibitors Market Size and Growth, 2017-2021 (USD Million)
Figure PD-1 inhibitors Market Size and Growth, 2017-2021 (in Volume)
Table PD-1 inhibitors CAGR by Revenue and Volume, 2017-2021
4.1.2 PD-L1 inhibitors Market, 2017-2021
Figure PD-L1 inhibitors Market Size and Growth, 2017-2021 (USD Million)
Figure PD-L1 inhibitors Market Size and Growth, 2017-2021 (in Volume)
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2017-2021
4.1.3 CTLA-4 inhibitors Market, 2017-2021
Figure CTLA-4 inhibitors Market Size and Growth, 2017-2021 (USD Million)
Figure CTLA-4 inhibitors Market Size and Growth, 2017-2021 (in Volume)
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2017-2021
4.2 Market Forecast
4.2.1 PD-1 inhibitors Market Forecast, 2022-2028
Figure PD-1 inhibitors Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure PD-1 inhibitors Market Estimates and Forecasts, 2022-2028 (in Volume)
Table PD-1 inhibitors CAGR by Revenue and Volume, 2018-2028
4.2.2 PD-L1 inhibitors Market Forecast, 2022-2028
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2022-2028 (in Volume)
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2018-2028
4.2.3 CTLA-4 inhibitors Market Forecast, 2022-2028
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2022-2028 (in Volume)
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2018-2028
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Melanoma treatment Market, 2017-2021
Figure Melanoma treatment Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Melanoma treatment CAGR by Revenue and Volume, 2017-2021
5.1.2 Bladder cancer treatment Market, 2017-2021
Figure Bladder cancer treatment Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Bladder cancer treatment CAGR by Revenue and Volume, 2017-2021
5.1.3 Others Market, 2017-2021
Figure Others Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Others CAGR by Revenue and Volume, 2017-2021
5.2 Market Forecast
5.2.1 Melanoma treatment Market Forecast, 2022-2028
Figure Melanoma treatment Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Melanoma treatment Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Melanoma treatment CAGR by Revenue and Volume, 2022-2028
5.2.2 Bladder cancer treatment Market Forecast, 2022-2028
Figure Bladder cancer treatment Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Bladder cancer treatment Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Bladder cancer treatment CAGR by Revenue and Volume, 2022-2028
5.2.3 Others Market Forecast, 2022-2028
Figure Others Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Others Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Others CAGR by Revenue and Volume, 2022-2028
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2017-2021
Figure Asia-Pacific Market Size and Growth, 2017-2021 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2017-2021 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2017-2021
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2017-2021
Figure North America Market Size and Growth, 2017-2021 (USD Million)
Figure North America Market Size and Growth, 2017-2021 (in Volume)
Table North America CAGR by Revenue and Volume, 2017-2021
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2017-2021
Figure Europe Market Size and Growth, 2017-2021 (USD Million)
Figure Europe Market Size and Growth, 2017-2021 (in Volume)
Table Europe CAGR by Revenue and Volume, 2017-2021
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2017-2021
Figure South America Market Size and Growth, 2017-2021 (USD Million)
Figure South America Market Size and Growth, 2017-2021 (in Volume)
Table South America CAGR by Revenue and Volume, 2017-2021
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2017-2021
Figure Middle East & Africa Market Size and Growth, 2017-2021 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2017-2021 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2017-2021
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2022-2028
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2022-2028
6.2.2 North America Market Forecast, 2022-2028
Figure North America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure North America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table North America CAGR by Revenue and Volume, 2022-2028
6.2.3 Europe Market Forecast, 2022-2028
Figure Europe Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Europe Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Europe CAGR by Revenue and Volume, 2022-2028
6.2.4 South America Market Forecast, 2022-2028
Figure South America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure South America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table South America CAGR by Revenue and Volume, 2022-2028
6.2.5 Middle East & Africa Market Forecast, 2022-2028
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2022-2028
7 Market Competitive
7.1 Global Market by Vendors
Table Global Checkpoint Inhibitors for Treating Cancer Market by Vendors, 2017-2021 (in Volume)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2017-2021 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2017-2021 (in Volume)
7.2 Market Concentration
Figure Checkpoint Inhibitors for Treating Cancer Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bristol-Myers Squibb(BMS)
Table Bristol-Myers Squibb(BMS) Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Merck
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo
×

Avail PDF Sample Reports

You may also be lnterested in..

Research Allied Copyright © 2024 .